3Jhund PS, Macintyre K, Simpson CR, et al. Long-term trends in first hos- pitalization for heart failure and subsequent survival between 1986 and2003 : a population study of 5,1 million people [ J ]. Circulation, 2009, 119(4) :515 -523.
4Goldberg R J, Spencer FA, Farmer C, et al. Incidence and hospital death rates associated with heart failure :a community-wide perspective [ J ]. Am J Med,2005,118(7) :728 -734.
5Bleumink GS, Knetsch AM, Suturkenboom MC, et al. Quantifying the heart failure epidemic : prevalence, incidence rate ,lifetime risk and prog- nosis of heart failure the rotterdam study [ J ]. Eur Heart J, 2004,25 (18) :1614 -1619.
7Burger A J, Horton DP, LeJemtel T, et al. Effect of nesiritide ( B-typena- triuretic peptide) and dobutamine on ventricular arrhythmias in the treat- ment of patients with acutely decompensated congestive heart failure: the precedent study[ J]. Am Heart J ,2002,144 : 1102 - 1108.
8Rognoni A, Lupi A, Lazzero M, et al. Levosimendan : from basic science to clinical trials [ J ]. Recent Pat Cardiovasc Drug Discov, 2011,6 : 9 - 15.
